Sudarshan Chemical Industries: Transcript of Investor Call Released
Sudarshan Chemical Industries released its investor call transcript for Q4 FY26. The company is integrating the Heubach business, facing challenges but rebuilding customer trust. Net debt reduced to ₹755 crore by March 2026. They project €90-100 million EBITDA in 3-4 years and €35 million for FY27. Inventory reduced by €29 million in Q4.
The announcement provides an update on the company's integration progress, financial performance, and future outlook following the acquisition of Heubach. This information is material for investors and analysts, impacting their understanding of the company's strategic direction and financial health.
The announcement is a factual release of a conference call transcript. While it details efforts to overcome integration challenges and improve financial metrics, it also acknowledges ongoing geopolitical and cost pressures. The sentiment is neutral as it presents a balanced view of progress and challenges.
Sudarshan Chemical Industries Limited has released the transcript of their conference call with Analysts and Institutional Investors, which took place on May 27, 2026. This call followed the announcement of the Audited Financial Results for the quarter and financial year ended March 31, 2026. The transcript is available on the company's website, www.sudarshan.com.
During the call, management discussed the integration of the Heubach business, acquired in March 2025, which involved combining entities from Clariant and Heubach. Challenges faced included integrating three companies, profitability pressures, high working capital, and broken supply chain processes. The company focused on rebuilding customer trust, achieving value capture initiatives, and aligning the organization with a 'One Sudarshan' culture. A significant undertaking is the 'One SAP Drive project Integra' to integrate multiple systems by year-end.
For Q4 FY26, the acquired group delivered a Business EBITDA of €11 million against a projection of €9-10 million and reduced inventory by €29 million. The net debt reduced from ₹934 crore in December 2025 to ₹755 crore in March 2026. The company is navigating challenges from the Middle East crisis, including increased raw material and energy costs, and is focused on passing these costs to customers while maintaining volumes. The company expects to achieve €90 million to €100 million in EBITDA over the next 3 to 4 years, with a projected EBITDA of €35 million for the next financial year.
Discussions also covered the RIECO business performance, which saw revenue growth of 17.5% to ₹268 crore in FY26, with EBITDA turning positive to ₹10 crore. The company is working on further transformation for RIECO. Management also addressed inventory levels, noting a reduction of €29 million in Q4 and targeting a further €15-20 million reduction. Customer trust has been rebuilt, and customers have started purchasing again. The company anticipates that reported and business EBITDA will merge going forward as inventory levels normalize.
What to do with a filing like this
Sudarshan Chemical Industries Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sudarshan Chemical Industries Limited. Read the original for the full detail.